The Complete Guide to Ozempic Injury Claims and Lawsuit Eligibility

What You Need to Know About Ozempic Injury Claims

Ozempic injury claims are legal actions filed by patients who suffered serious side effects — like stomach paralysis, vision loss, or bowel damage — after taking semaglutide-based drugs such as Ozempic, Wegovy, or Rybelsus.

Here is a quick overview of the key facts:

Millions of Americans have taken Ozempic or a related drug. About 12% of U.S. adults have used a GLP-1 drug, and between 2022 and 2023 alone, nearly 25,000 emergency room visits were linked to semaglutide medications. Yet many patients say they were never warned about the risks that landed them in the hospital.

The lawsuits allege that Novo Nordisk knew — or should have known — about these dangers and failed to tell doctors and patients. That is the core of most Ozempic injury claims today.

I'm Tim Burd, CEO of Justice Hero, a legal services company that helps people identify whether they qualify for medical mass tort lawsuits and connects them with the right legal representation. Through my work in mass tort litigation strategy, I've helped thousands of people navigate Ozempic injury claims and similar pharmaceutical cases. In the guide below, I'll walk you through everything you need to know to understand your options.

Ozempic injury claims terms explained:

• Ozempic chronic diarrhea
• Ozempic severe nausea
• Ozempic gallbladder lawsuit

Understanding Ozempic and Semaglutide-Based Medications

To understand why Ozempic injury claims are flooding the courts, we first need to look at what these drugs actually are. Ozempic is the brand name for semaglutide, a medication that belongs to a class known as GLP-1 receptor agonists.

The FDA originally approved Ozempic in 2017 to help adults with Type 2 diabetes manage their blood sugar levels. It works by mimicking a natural hormone in your body (glucagon-like peptide-1) that signals your pancreas to create more insulin and tells your brain you are full. It also slows down "gastric emptying"—the speed at which food leaves your stomach.

While Ozempic is only FDA-approved for diabetes, its sister drug, Wegovy, was approved in 2021 specifically for chronic weight management. Rybelsus is an oral tablet version of the same active ingredient. Because of their effectiveness in shedding pounds, these drugs exploded in popularity, often being prescribed "off-label" for weight loss.

However, the very mechanism that makes these drugs work—slowing down digestion—is exactly what is causing the severe injuries cited in most Ozempic injury claims. When the stomach slows down too much, or stops entirely, the results can be catastrophic.

Serious Side Effects and Ozempic Injury Claims

While common side effects like mild nausea or "Ozempic face" (skin sagging from rapid weight loss) have made headlines, the legal battle centers on life-altering medical conditions. Our research shows that nearly 70% of ER visits linked to these drugs are due to severe gastrointestinal reactions.

The most common injuries alleged in Ozempic injury claims include:

• Gastroparesis (Stomach Paralysis): This is a condition where the muscles in the stomach wall stop working, preventing the stomach from emptying properly. This leads to persistent vomiting (sometimes of food eaten days prior), intense pain, and malnutrition.
• NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy): Often described as an "eye stroke," this condition involves sudden, permanent vision loss because blood flow to the optic nerve is blocked. Recent studies suggest semaglutide users may face a risk more than four times higher than those on other medications.
• Ileus and Bowel Obstruction: These are blockages in the intestines that prevent food and waste from passing through. Research indicates that GLP-1 users are 3.5 to 4.5 times more likely to report intestinal obstructions.
• Bowel Perforation: A life-threatening hole in the wall of the stomach or intestines, often requiring emergency surgery.
• Gallbladder Disease: Rapid weight loss and the drug's effect on bile can lead to gallstones or the need for gallbladder removal.

Gastrointestinal vs. Vision Injury Statistics

If you have experienced abnormal gastrointestinal functioning or sudden changes in your sight, you may be looking at a long road to recovery. These aren't just "stomach aches"; they are permanent changes to how your body functions.

Who Qualifies to File Ozempic Injury Claims?

Not everyone who feels sick after taking Ozempic can file a lawsuit. To have a viable Ozempic injury claim, we generally look for a specific set of criteria that demonstrate both use and significant harm.

Typical eligibility requirements include:

1. Proof of Use: You must have a valid prescription for Ozempic, Wegovy, or Rybelsus.
2. Specific Diagnosis: You need a medical diagnosis of one of the "signature" injuries, such as gastroparesis, ileus, or NAION.
3. Severe Complications: Most successful claims involve an emergency room visit or a hospital admission.
4. Timing: The injury must have occurred while you were taking the drug or within a short window (usually 30 days) after stopping.
5. No Prior History: If you had stomach paralysis or severe intestinal issues before starting the medication, it becomes much harder to prove the drug was the cause.

We often see age limits in these cases as well; many firms focus on plaintiffs who are age 75 or younger to ensure the injury isn't attributed to general age-related decline.

Proving Causation in Ozempic Injury Claims

The biggest hurdle in any pharmaceutical lawsuit is proving "causation"—the direct link between the drug and your injury. Novo Nordisk frequently argues that conditions like gastroparesis are actually caused by the patient's underlying diabetes, not the medication.

To fight back, attorneys rely on JAMA Network research and specific diagnostic tests. For stomach paralysis claims, a Gastric Emptying Study (scintigraphy) is often the "gold standard" of evidence. This test involves eating a meal with a tiny amount of radioactive material so doctors can watch how fast it leaves your stomach.

For vision loss, NAION clinical data is used to show that the "eye stroke" happened shortly after starting a high dose of semaglutide, often in patients who had no previous history of optic nerve issues.

Current Status of Ozempic Litigation and MDLs

As of January 5, 2026, there are 3,063 active lawsuits against Novo Nordisk and other GLP-1 manufacturers. Because there are so many similar cases, the court system has used a process called Multidistrict Litigation (MDL) to handle them efficiently.

There are currently two distinct MDLs for Ozempic injury claims:

1. MDL 3094 (GI Injuries): This is the primary litigation focused on stomach paralysis, ileus, and other digestive issues. It is being overseen by Judge Karen S. Marston in the Eastern District of Pennsylvania.
2. MDL 3163 (NAION Vision Loss): Created in late 2025, this separate MDL handles claims that the drugs caused permanent blindness or vision impairment.

Why aren't these class actions? In a class action, one person represents everyone, and everyone gets the same small check. In an MDL, your case remains your own. If there is a settlement, your payout is based on your specific medical bills, your lost wages, and your level of suffering.

The core of the legal argument is Failure to Warn. Plaintiffs allege that while Novo Nordisk knew about the risks of stomach paralysis and vision loss, they didn't update the warning labels until forced to by the FDA or mounting pressure. For example, the FDA only added a warning for "ileus" (intestinal blockage) in September 2023, years after many people had already been injured.

Compensation and Legal Deadlines for Victims

If you have been harmed, you are likely wondering what a settlement might look like. While no "global settlement" has been reached yet, legal analysts estimate that Novo Nordisk may pay roughly $2 billion in total compensation.

Based on similar pharmaceutical litigations, we can project potential settlement tiers:

• Tier 1 (High Severity): $400,000 to $700,000+. This usually applies to cases involving permanent disability, multiple surgeries, or death.
• Tier 2 (Moderate Severity): $150,000 to $400,000. This often includes patients with confirmed gastroparesis who required long-term hospitalization but have seen some improvement.
• Tier 3 (Lower Severity): $50,000 to $150,000. This might cover cases with significant medical bills and pain but fewer permanent lifestyle changes.

You can seek damages for medical expenses, lost income, and "pain and suffering." For more details on these medications, you can visit the official manufacturer sites for Wegovy and Rybelsus, though keep in mind these sites are designed to market the drugs, not highlight their litigation risks.

Important: The Statute of Limitations

Every state has a "statute of limitations," which is a deadline for filing your claim. In some states, you may only have one or two years from the date you discovered your injury to take action. Because of the "discovery rule," the clock usually starts when you realized Ozempic might be the cause of your problems, but waiting too long can permanently bar you from seeking justice.

Frequently Asked Questions about Ozempic Claims

What is the difference between the two Ozempic MDLs?

The two MDLs exist because the medical evidence for a stomach injury is completely different from the evidence for a vision injury. MDL 3094 handles "gut" issues like gastroparesis and bowel obstructions. MDL 3163 handles "eye" issues like NAION. By separating them, the court can move faster and use the right medical experts for each group.

Has the FDA issued warnings about Ozempic and stomach paralysis?

The FDA has updated the Ozempic label several times. In September 2023, they added a warning for "ileus" (intestinal blockage). In early 2025, they updated the label again to warn about severe gastrointestinal reactions and kidney risks. However, many attorneys argue these warnings still don't go far enough in explicitly mentioning "gastroparesis" or "stomach paralysis" as a primary risk.

Can I file a claim if I used Ozempic off-label for weight loss?

Yes. Many plaintiffs in the current MDL were prescribed Ozempic off-label for weight loss before Wegovy was widely available or because their insurance wouldn't cover Wegovy. The manufacturer is still responsible for warning about the drug's risks, regardless of whether you were using it for diabetes or weight management.

Conclusion

The rise of Ozempic injury claims represents one of the most significant pharmaceutical litigations in recent years. As millions continue to use these "miracle" drugs, the number of people discovering hidden, life-altering side effects continues to grow.

At Justice Hero, we believe in corporate accountability. If a multi-billion dollar company like Novo Nordisk chooses to downplay risks to protect profits, the people who suffer the consequences deserve a voice. Your legal rights are precious, and the window to protect them is often smaller than you think.

If you or a loved one have suffered from stomach paralysis, permanent vision loss, or a bowel obstruction after using semaglutide, you shouldn't have to carry the financial burden of your medical bills alone. We encourage you to seek an Ozempic injury claims evaluation to see where you stand in this evolving legal landscape.

For more information on the specifics of the litigation, check out our other guides:

• How much is the Ozempic lawsuit payout?
• Ozempic lawsuit guide 2025
• Gallbladder removal complete guide